natgillin/translations-raw huggingface dataset:
Commission Regulation (EC) No 798/2008 of 8 August 2008 laying down a list of third countries, territories, zones or compartments from which poultry and poultry products may be imported into and transit through the Community and the veterinary certification requirements [3] provides that the commodities covered by it are only to be imported into and transited through the Union from the third countries, territories, zones or compartments listed in the table in Part 1 of Annex I thereto.
Uredba Komisije (ES) št. 798/2008 z dne 8. avgusta 2008 o določitvi seznama tretjih držav, ozemelj, območij ali kompartmentov, iz katerih se dovolita uvoz perutnine in perutninskih proizvodov v Skupnost in njihov tranzit skozi Skupnost, ter zahtevah za izdajanje veterinarskih spričeval [3] določa, da sta uvoz blaga iz navedene uredbe v Unijo in njegov tranzit skozi Unijo dovoljena samo iz tretjih držav, ozemelj, območij ali kompartmentov s seznama razpredelnice v delu 1 Priloge I k Uredbi.
Pursuant to Regulation (EC) No 798/2008, where an outbreak of highly pathogenic avian influenza (HPAI) occurs in a third country, territory, zone or compartment previously free of that disease, that third country, territory, zone or compartment is to again be considered as free of HPAI, provided that certain conditions are met. Those conditions concern the implementation of a stamping out policy to control the disease, including adequate cleansing and disinfection carried out on all previously infected establishments.
V skladu z Uredbo (ES) št. 798/2008 se pri izbruhu visoko patogene aviarne influence (HPAI) v tretji državi, na ozemlju, območju ali v kompartmentu, ki je bil prej prost aviarne influence, za navedeno tretjo državo, ozemlje, območje ali kompartment šteje, da je ponovno prosto HPAI, če so izpolnjeni nekateri pogoji, ki se nanašajo na politiko pokončanja in uničenja okuženih živali za nadzor nad boleznijo, vključno z ustreznim čiščenjem in razkuževanjem vseh v preteklosti okuženih obratov.
Israel is listed in Part 1 of Annex I to Regulation (EC) No 798/2008 as a third country from which all poultry commodities covered by that Regulation may be imported into the Union.
Izrael je na seznamu v delu 1 Priloge I k Uredbi (ES) št. 798/2008 naveden kot tretja država, iz katere se lahko vsi perutninski proizvodi iz navedene uredbe uvažajo v Unijo.
Following a HPAI outbreak in early 2010 imports of certain commodities from Israel to the Union were restricted to defined parts of its territory by that Regulation, as amended by Commission Regulation (EU) No 332/2010 [4].
Zaradi izbruha HPAI v začetku leta 2010 je bil omejen uvoz določenih produktov iz Izraela v Unijo na določena območja njenega območja iz navedene uredbe, kakor je bila spremenjena z Uredbo Komisije (EU) št. 332/2010 [4].
In addition, on 8 March 2011 Israel has notified the Commission of an outbreak of HPAI of the H5N1 subtype on its territory.
Poleg tega je Izrael 8. marca 2011 Komisijo obvestil o izbruhu HPAI podtipa H5N1 na svojem ozemlju.
Israel has submitted information to the Commission on the control measures taken in relation to the recent outbreak of the disease.
Izrael je Komisiji predložil informacije o izvedenih nadzornih ukrepih v zvezi z nedavnim izbruhom bolezni.
Israel has implemented a stamping out policy in order to control the disease and limit its spread.
Izrael je izvedel politiko pokončanja in uničenja okuženih živali za nadzor nad boleznijo in omejitev njenega širjenja.
The prompt and decisive action taken by Israel to confine the disease and the positive outcome of the evaluation of the epidemiological situation allow limiting the restrictions on imports into the Union for certain poultry commodities to the zone affected by the disease, which the veterinary authorities of Israel have placed under restrictions.
Takojšnji in odločni ukrepi Izraela za omejitev bolezni in pozitivni rezultati ocenjevanja epidemiološkega stanja omogočajo, da se omejitve uvoza nekaterih perutninskih proizvodov v Unijo uporabljajo le za območja, ki jih je prizadela bolezen in za katere so izraelski veterinarski organi uvedli omejitve.
Taking into account the favourable development of the epidemiological situation and the surveillance activities for avian influenza in resolving the outbreak in accordance with the conditions set out in Regulation (EC) No 798/2008, it is appropriate to limit the time period during which the authorisation for imports into the Union is suspended to a three-month period until 14 June 2011 following adequate cleansing and disinfection of the previously infected holding.
Ob upoštevanju ugodnega razvoja epidemiološkega stanja in nadzornih dejavnosti za aviarno influenco pri omejevanju izbruha je primerno v skladu s pogoji iz Uredbe (ES) št. 798/2008 omejiti obdobje, v katerem je odobritev uvoza v Unijo začasno ustavljena za tri mesece do 14. junija 2011 po ustreznem čiščenju in razkuževanju vseh v preteklosti okuženih obratov.
In Part 1 of Annex I to Regulation (EC) No 798/2008, the entry for Israel is replaced by the text in the Annex to this Regulation.
V delu 1 Priloge I k Uredbi (ES) št. 798/2008 se vnos za Izrael nadomesti z besedilom iz Priloge k tej uredbi.
OJ L 102, 23.4.2010, p. 10.
UL L 102, 23.4.2010, str. 10.
Area of Israel excluding IL-2 and IL-3
Območje Izraela, razen IL-2 in IL-3
to the west: road number 4,
zahodno: cesta št. 4,
to the south: road number 5812 connecting to road number 5815,
južno: cesta št. 5812, ki se poveže s cesto št. 5815,
to the east: the security fence until road number 6513,
vzhodno: varnostna ograja do ceste št. 6513,
to the north: road 386 until municipal boundaries of Jerusalem, the Refaim river, the former Israel Jordan border (“green line”),
severno: cesta št. 386 do občinskih mej Jeruzalema, reke Refaim, nekdanje meje med Izraelom in Jordanijo (‚zelena meja‘),
to the east: road 356,
vzhodno: cesta št. 356,
to the south: roads 8670, 3517 and 354,
južno: ceste št. 8670, 3517 in 354,
to the west: a straight line going north until road 367, following 367 west and then north until road 375 and west of the village of Matta a north-north-east line to road 386.
zahodno: ravna črta proti severu do ceste št. 367, po cesti št. 367 na zahodu in nato proti severu do ceste št. 375 in zahodno od vasi Matta severno-severno vzhodna črta do ceste št. 386.
The area from which imports of certain commodities were prohibited is described in column 3 with the code IL-2 in the entry for Israel in Part 1 of Annex I to Regulation (EC) No 798/2008 and applied until 1 May 2010.
Območje, iz katerega je bil omejen uvoz določenih produktov, je opisano v stolpcu 3 s kodo IL-2 v vnosu za Izrael v delu 1 Priloge I k Uredbi (ES) št. 798/2008 in se uporablja do 1. maja 2010.
However, the prohibition of imports of certain poultry commodities from IL-2 in relation to that outbreak should continue for commodities produced before that date.
Vendar bi se moral omejen uvoz določenih perutninskih proizvodov iz IL-2 v zvezi z navedenim izbruhom nadaljevati tudi za proizvode, ki so bili proizvedeni pred navedenim datumom.
Due to the confirmed outbreak of HPAI, the territory of Israel may no longer be considered as free from that disease.
Zaradi potrjenega izbruha HPAI se območje Izraela ne bo več štelo za prosto navedene bolezni.
As a consequence, the veterinary authorities of Israel have suspended issuing veterinary certificates for consignments of certain poultry commodities accordingly.
Posledično so izraelski veterinarski organi začasno ustavili izdajanje veterinarskih spričeval za pošiljke nekaterih perutninskih proizvodov.
Commission Regulation (EU) No 428/2011
Uredba Komisije (EU) št. 428/2011
A battery-powered apparatus in the form of a cylinder with dimensions of approximately 21 cm in height with a diameter of 9 cm and a weight of approximately 310 g (so-called ‘aerosol dispenser’) specifically designed to be used together with an interchangeable aerosol can.
Naprava na baterije cilindrične oblike z dimenzijami približno 21 cm v višino, premerom 9 cm ter maso približno 310 g (tako imenovani „aerosolni razpršilnik“), oblikovan posebej za uporabo z zamenljivo aerosolno dozo.
The apparatus comprises:
Napravo sestavljajo:
an electromechanical system for the activation of the spraying mechanism of the aerosol can,
elektromehanski sistem za sprožitev razpršilnega mehanizma aerosolne doze,
a sensor and buttons for activation of the electromechanical system, and
senzor in gumbe za sprožitev elektromehanskega sistema ter
a plastic housing with an aperture enabling the dispersal of aerosol when the electromechanical system is activated.
plastično ohišje z odprtino, skozi katero se ob sprožitvi elektromehanskega sistema razprši aerosol.
The apparatus, when equipped with an aerosol can, is capable of freshening air within a limited space inside a building by dispersing portions of fragrance, either when the sensor detects the presence of a person, or at regular pre-set intervals.
Naprava, ki je opremljena z aerosolno pločevinko, lahko osveži zrak na omejenem prostoru znotraj zgradbe, in sicer z razpršitvijo odmerka dišave bodisi kadar senzor zazna premikanje človeka bodisi v rednih, predhodno nastavljenih intervalih.
Classification is determined by General Rules 1 and 6 for the interpretation of the Combined Nomenclature, Note 3(b) to Chapter 85 and by the wording of CN codes 8509 and 85098000.
Uvrstitev je določena s splošnima praviloma 1 in 6 za razlago kombinirane nomenklature, opombo 3(b) k poglavju 85 ter z besedilom oznak KN 8509 in 85098000.
Given that the apparatus itself does not project, disperse or spray but merely activates the spraying mechanism of the aerosol can, classification under heading 8424 is excluded.
Glede na to, da sama naprava ne brizga, škropi ali razpršuje, temveč samo sproži razpršilni mehanizem aerosolne doze, se uvrstitev v tarifno številko 8424 izključi.
The apparatus is an electromechanical appliance with a self-contained motor of heading 8509 of the kind commonly used for domestic purposes.
Naprava je elektromehanski pripomoček z lastnim motorjem iz tarifne številke 8509, ki je običajno namenjen za gospodinjsko rabo.
It is therefore to be classified under CN code 85098000.
Izdelek se zato uvrsti pod oznako KN 85098000.
an electromechanical appliance (so-called ‘aerosol dispenser’), and
elektromehanski pripomoček (tako imenovani „aerosolni razpršilnik“) in
an interchangeable aerosol can.
zamenljiva aerosolna doza.
The ‘aerosol dispenser’ is a battery-powered apparatus in the form of a cylinder with dimensions of approximately 21 cm in height with a diameter of 9 cm and a weight of approximately 310 g comprising:
„Aerosolni razpršilec“ je naprava na baterije cilindrične oblike z dimenzijami približno 21 cm v višino, premerom 9 cm ter maso približno 310 g, ki vsebuje:
The aerosol can contains a prepared room deodoriser, perfumed, of CN code 33074900.
Aerosolna pločevinka vsebuje preparat parfumiranega dezodoranta za prostore, uvrščen pod oznako KN 33074900.
The ‘aerosol dispenser’, when equipped with an aerosol can, is capable of freshening air within a limited space inside a building by dispersing portions of fragrance, either when the sensor detects the presence of a person, or at regular pre-set intervals.
„Aerosolni razpršilec“, ki je opremljen z aerosolno dozo, lahko osveži zrak na omejenem prostoru znotraj zgradbe, in sicer z razpršitvijo odmerka dišave bodisi kadar senzor zazna premikanje človeka bodisi v rednih, predhodno nastavljenih intervalih.
The aerosol can is consumable goods which can be replaced when empty by another aerosol can of the same dimensions.
Aerosolna doza je potrošno blago in se jo po izpraznitvi lahko zamenja z novo aerosolno dozo istih dimenzij.
Classification is determined by General Rules 1, 3(b) and 6 for the interpretation of the Combined Nomenclature, Note 3(b) to Chapter 85 and by the wording of CN codes 8509 and 85098000.
Uvrstitev je določena s splošnimi pravili 1, 3(b) in 6 za razlago kombinirane nomenklature, opombo 3(b) k poglavju 85 ter z besedilom oznak KN 8509 in 85098000.
The component that gives the set its essential character is the aerosol dispenser because it is permanently used, whereas the aerosol can has to be replaced when empty.
Sestavina, ki kompletu daje ključno značilnost, je aerosolni razpršilnik, saj se ga uporablja stalno, medtem ko je aerosolno dozo treba zamenjati, ko se izprazni.
The set is therefore to be classified under CN code 85098000.
Izdelek se zato uvrsti pod oznako KN 85098000.
Commission Implementing Regulation (EU) No 429/2011
Izvedbena uredba Komisije (EU) št. 429/2011
This Regulation shall enter into force on 3 May 2011.
Ta uredba začne veljati 3. maja 2011.
Commission Implementing Regulation (EU) No 430/2011
Izvedbena uredba Komisije (EU) št. 430/2011
These prices and duties have been last amended by Commission Regulation (EU) No 424/2011 [4].
Navedene cene in dolžnosti so bile nazadnje spremenjene z Uredbo Komisije (EU) št. 424/2011 [4].
OJ L 111, 30.4.2011, p. 14.
UL L 111, 30.4.2011, str. 14.
Amended representative prices and additional import duties applicable to white sugar, raw sugar and products covered by CN code 17029095 from 3 May 2011
Spremenjene reprezentativne cene in dodatne uvozne dajatve za beli in surovi sladkor ter proizvode z oznako KN 17029095, ki se uporabljajo od 3. maja 2011
Commission Implementing Regulation (EU) No 431/2011
Izvedbena uredba Komisije (EU) št. 431/2011
This Regulation shall enter into force on 4 May 2011.
Ta uredba začne veljati 4. maja 2011.
Commission Regulation (EU) No 432/2011
Uredba Komisije (EU) št. 432/2011
of 4 May 2011
z dne 4. maja 2011
Following an application from Gencor Pacific Inc, submitted on 10 November 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of ethanol-water extract of Caralluma fimbriata (Slimaluma®) on help to reduce waist circumference (Question No EFSA-Q-2010-00027) [2].
Družba Gencor Pacific Inc je 10. novembra 2009 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki etanolno-vodnega izvlečka iz Caralluma fimbriata (Slimaluma®) na zmanjševanje obsega pasu (vprašanje št. EFSA-Q-2010-00027) [2].
The claim proposed by the applicant was worded, as follows: ‘Slimaluma® helps to reduce waist circumference’.
Vložnik je predlagal naslednjo trditev: „Slimaluma® pomaga zmanjšati obseg pasu.“
On 12 May 2010 and on 18 May 2010, the Commission and the Member States received the scientific opinion from the Authority and its amendment respectively, which concluded that on the basis of the data submitted, a cause and effect relationship had not been established between the consumption of Slimaluma® and the beneficial physiological effect as defined by the Authority, namely, reduction of waist circumference leading to an improvement in adverse health effects associated with an excess abdominal fat.
Komisija in države članice so 12. maja 2010 in 18. maja 2010 prejele znanstveno mnenje Agencije in njegovo spremembo, v katerih je Agencija na podlagi predloženih podatkov ugotovila, da ni utemeljena vzročno-posledična povezava med uživanjem Slimaluma® in pozitivnim fiziološkim učinkom, kot ga je opredelila Agencija, in sicer zmanjšanje obsega pasu, ki privede do zmanjšanja škodljivih učinkov na zdravje, povezanih z odvečno trebušno maščobo.
Following an application from Gencor Pacific Inc, submitted on 10 November 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of ethanol-water extract of Caralluma fimbriata (Slimaluma®) on help to reduce body fat (Question No EFSA-Q-2010-00028) [3].
Družba Gencor Pacific Inc je 10. novembra 2009 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki etanolno-vodnega izvlečka iz Caralluma fimbriata (Slimaluma®) na odpravljanje telesne maščobe (vprašanje št. EFSA-Q-2010-00028) [3].
The claim proposed by the applicant was worded, as follows: ‘Slimaluma® helps to reduce body fat’.
Vložnik je predlagal naslednjo trditev: „Slimaluma® pomaga odpravljati telesno maščobo.“
On 12 May 2010, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data submitted, a cause and effect relationship had not been established between the consumption of Slimaluma® and the claimed effect.
Komisija in države članice so 12. maja 2010 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da vzročno-posledična povezava med uživanjem Slimaluma® in navedeno trditvijo ni utemeljena.
Following an application from Gencor Pacific Inc, submitted on 10 November 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of ethanol-water extract of Caralluma fimbriata (Slimaluma®) on help to reduce body weight (Question No EFSA-Q-2010-00029) [4].
Družba Gencor Pacific Inc je 10. novembra 2009 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki etanolno-vodnega izvlečka iz Caralluma fimbriata (Slimaluma®) na zmanjševanje telesne teže (vprašanje št. EFSA-Q-2010-00029) [4].
The claim proposed by the applicant was worded, as follows: ‘Slimaluma® helps to reduce body weight’.
Vložnik je predlagal naslednjo trditev: „Slimaluma® pomaga zmanjševati telesno težo.“
Following an application from Gencor Pacific Inc, submitted on 10 November 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of ethanol-water extract of Caralluma fimbriata (Slimaluma®) on decreased energy intake (Question No EFSA-Q-2010-00030) [5].
Družba Gencor Pacific Inc je 10. novembra 2009 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki etanolno-vodnega izvlečka iz Caralluma fimbriata (Slimaluma®) na zmanjšan vnos energije (vprašanje št. EFSA-Q-2010-00030) [5].
The claim proposed by the applicant was worded, as follows: ‘Slimaluma® helps to reduce caloric intake’.
Vložnik je predlagal naslednjo trditev: „Slimaluma® pomaga zmanjšati vnos kalorij.“
Following an application from Gencor Pacific Inc, submitted on 10 November 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of ethanol-water extract of Caralluma fimbriata (Slimaluma®) on help to control hunger/appetite (Question No EFSA-Q-2010-00031) [6].
Družba Gencor Pacific Inc je 10. novembra 2009 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki etanolno-vodnega izvlečka iz Caralluma fimbriata (Slimaluma®) na nadzor lakote/apetita (vprašanje št. EFSA-Q-2010-00031) [6].
The claim proposed by the applicant was worded, as follows: ‘Slimaluma® helps to control hunger/appetite’.
Vložnik je predlagal naslednjo trditev: „Slimaluma® pomaga nadzorovati lakoto/apetit.“
On 12 May 2010, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data submitted, a cause and effect relationship had not been established between the consumption of Slimaluma® and the beneficial physiological effect as defined by the Authority, namely, reduction of appetite leading to a reduction in subsequent energy intake.
Komisija in države članice so 12. maja 2010 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da ni utemeljene vzročno-posledične povezave med uživanjem Slimaluma® in pozitivnim fiziološkim učinkom, kot ga je opredelila Agencija, in sicer zmanjšanje apetita, ki privede do zmanjšanja vnosa energije.
Following an application from Leiber GmbH, submitted on 2 October 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Yestimun® on immune responses (Question No EFSA-Q-2008-667) [7].
Družba Leiber GmbH je 2. oktobra 2009 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki Yestimun® na odzive imunskega sistema (vprašanje št. EFSA-Q-2008-667) [7].
The claim proposed by the applicant was worded, inter alia, as follows: ‘Daily administration of Yestimun® strengthens the body’s defence during the cold season’.
Vložnik je med drugim predlagal naslednjo trditev: „Dnevni vnos Yestimun® okrepi telesno odpornost v mrzlih dneh.“
On 27 May 2010, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data submitted, a cause and effect relationship had not been established between the consumption of Yestimun® and the initiation of appropriate innate and adaptive immune responses.
Komisija in države članice so 27. maja 2010 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da vzročno-posledična povezava med uživanjem Yestimun® in sprožitvijo ustreznih naravnih in prilagodljivih odzivov imunskega sistema ni utemeljena.
Following an application from Laboratoires innéov SNC, submitted on 30 December 2008 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of blackcurrant seed oil (Ribes nigrum), fish oil, lycopene from tomato (Lycopersicon esculentum) extract, vitamin C and vitamin E on help to improve dry skin conditions (Question No EFSA-Q-2009-00767) [8].
Družba Laboratoires innéov SNC je 30. decembra 2008 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 vložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki olja iz semen črnega ribeza (Ribes nigrum), ribjega olja, likopena iz izvlečka paradižnika (Lycopersicon esculentum), vitamina C in vitamina E na izboljšanje stanja suhe kože (vprašanje št. EFSA-Q-2009-00767) [8].
The claim proposed by the applicant was worded, inter alia, as follows: ‘Helps to improve dry skin condition’.
Vložnik je predlagal naslednjo trditev: „Pomaga izboljšati stanje suhe kože.“
On 25 May 2010, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data submitted, a cause and effect relationship had not been established between the intake of a combination of blackcurrant seed oil (Ribes nigrum), fish oil, lycopene from tomato (Lycopersicon esculentum) extract, vitamin C and vitamin E and the claimed effect.
Komisija in države članice so 25. maja 2010 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da vzročno-posledična povezava med uživanjem kombinacije olja iz semen črnega ribeza (Ribes nigrum), ribjega olja, likopena iz izvlečka paradižnika (Lycopersicon esculentum), vitamina C in vitamina E ter navedeno trditvijo ni utemeljena.
The health claims related to Slimaluma® are health claims as referred to in point (c) of Article 13(1) of Regulation (EC) No 1924/2006 and are therefore subject to the transition period laid down in Article 28(6) of that Regulation.
Zdravstvene trditve v zvezi s Slimaluma® so zdravstvene trditve iz točke (c) člena 13(1) Uredbe (ES) št. 1924/2006, zato zanje velja prehodno obdobje iz člena 28(6) navedene uredbe.
However, as the applications were not made before 19 January 2008, the requirement provided for in point (b) of Article 28(6) of that Regulation is not fulfilled, and therefore those claims may not benefit from the transition period provided for in that Article.
Ker pa vloge niso bile predložene pred 19. januarjem 2008, zahteva iz točke (b) člena 28(6) navedene uredbe ni izpolnjena, zato se prehodno obdobje iz navedenega člena za navedene trditve ne more uporabiti.